.
ENTXW financial statements
* Numbers in thousands
Year |
2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|
Capitalization * |
0 | 0 | 0 | 0 |
EV * |
-7 506 | -14 886 | -8 161 | -8 161 |
Stock price $ |
0.96 | 0.363811 | 0.2399 | 0.223 |
Number of shares * |
0 | 0 | 0 | 0 |
EPS |
0,00 | 0,00 | 0,00 | 0,00 |
Revenue * |
500 | 236 | 365 | 365 |
Net income * |
-10 304 | -10 795 | -9 983 | -9 983 |
Operating profit * |
-10 861 | -11 454 | -11 133 | -11 133 |
Total liabilities * |
3 225 | 4 784 | 3 597 | 3 597 |
Net debt * |
-7 506 | -14 886 | -8 161 | -8 161 |
Total assets * |
13 341 | 16 703 | 10 262 | 10 262 |
Equity * |
10 116 | 11 919 | 6 665 | 6 665 |
Cash and investments * |
11 521 | 15 185 | 8 593 | 8 593 |
Over the past 10 years, the maximum capitalization of Entera Bio Ltd. WT EXP 062723 is 0, the minimum is 0. Maximum net income 0, Minimum net income -10 795. The maximum price of ENTXW shares is 0.96, the minimum price is 0.2399.
.
ENTXW valuation
Year |
2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|
P/E |
0,00 | 0,00 | 0,00 | 0,00 |
P/B |
0,00 | 0,00 | 0,00 | 0,00 |
P/S |
0,00 | 0,00 | 0,00 | 0,00 |
E/P |
0% | 0% | 0% | 0% |
P/FCF |
0,00 | 0,00 | 0,00 | 0,00 |
.
ENTXW profitability
Year |
2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|
ROE |
-102% | -91% | -150% | |
ROA |
-81% | -67% | -103% | |
ROIC |
-94% | -95% | -159% |